Research/art/teacher profile of a person
Name and surname:
PharmDr. Milica Molitorisová, PhD.
Document type:
Research/art/teacher profile of a person
The name of the university:
Comenius University Bratislava
The seat of the university:
Šafárikovo námestie 6, 818 06 Bratislava

I. - Basic information

I.1 - Surname
Molitorisová
I.2 - Name
Milica
I.3 - Degrees
PharmDr., PhD.
I.4 - Year of birth
1960
I.5 - Name of the workplace
Comenius University Bratislava, Faculty of Pharmacy
I.6 - Address of the workplace
Slovak Republic, Bratislava 832 32, Odbojarov Street 10
I.7 - Position
Vice-Dean for Educational Activities in the Study Programme Medical Devices and for Faculty's Development, Head of the Section of Medical Devices at the Department of Galenic Pharmacy
I.8 - E-mail address
milica.molitorisova@uniba.sk
I.9 - Hyperlink to the entry of a person in the Register of university staff
https://www.portalvs.sk/regzam/detail/5949
I.10 - Name of the study field in which a person works at the university
Medical and Diagnostic Devices and Pharmacy - Pharmaceutical Technology
I.11 - ORCID iD
0000-0002-3062-6499

II. - Higher education and further qualification growth

II.1 - First degree of higher education
II.a - Name of the university or institution
Comenius University Bratislava, Faculty of Pharmacy - joint 1.st and 2nd degree of study program PHARMACY - see more info bellow, in the part II.2 Second degree of higher education
II.b - Year
NA
II.c - Study field and programme
NA
II.2 - Second degree of higher education
II.a - Name of the university or institution
Comenius University Bratislava, Faculty of Pharmacy
II.b - Year
1983
II.c - Study field and programme
Pharmacy, study program: Clinical Pharmacy
II.3 - Third degree of higher education
II.a - Name of the university or institution
Slovak Medical University in Bratislava, Faculty of Public Health
II.b - Year
2016
II.c - Study field and programme
Public Health
II.4 - Associate professor
II.a - Name of the university or institution
NA (not applicable)
II.b - Year
NA
II.c - Study field and programme
NA
II.5 - Professor
II.a - Name of the university or institution
NA
II.b - Year
NA
II.c - Study field and programme
NA
II.6 - Doctor of Science (DrSc.)
II.a - Name of the university or institution
NA
II.b - Year
NA
II.c - Study field and programme
NA

III. - Current and previous employment

III.a - Occupation-position III.b - Institution III.c - Duration
Vice-Dean, Head of the Section at the Faculty´s Department, and before the Head of the Department of Galenic Pharmacy, and Head of the Deparment, Head of teacher in Pharmaceutical Technology, Medical Devices, and Social Pharmacy Comenius University Bratislava, Faculty of Pharmacy, Slovak Republic 8 years of employment, 3rd year in a positions of the Vice-Dean now, and 2 years Head of the Department, 3 years Head of the Section, teacher
Country Manager of Pharmaceutical Company Belupo, branch office, Prague, Czech Republic 3 years
General Manager of Pharmaceutical Company Sanofi-Aventis, Ltd. and Zentiva, Inc., Bratislava, Slovak Republic 20 years
Research oriented clinical pharmacist Institute of Preventive and Clinical Medicine, Bratislava 6 years
Pharmacist in Public Pharmacy National Health Insitute, Bratislava, Slovakia 2 years

IV. - Development of pedagogical, professional, language, digital and other skills

IV.a - Activity description, course name, other IV.b - Name of the institution IV.c - Year
Biodrug, Bratislava, Slovakia Good Clinical Practice (Cerificated Course) 2017 - 2018
Business Leadership Program (Cerificated Course) CEDEP, Fontainebleau, Francúzsko 2005 - 2006
Strategic Management and Quality Assurance (Cerificated Course) Ashridge Management College, UK 1999

V. - Overview of activities within the teaching career at the university

V.1 - Overview of the profile courses taught in the current academic year according to study programmes
V.1.a - Name of the profile course V.1.b - Study programme V.1.c - Degree V.1.d - Field of study
Medical Devices (this course is an obligatory one and a part of the state exam) Medical and Diagnostic Devices 1st Degree (Bachelor) Health Sciences
Good Manufacturing Practice - an elective obligatory course Pharmaceutical Technology 2nd (Master) Pharmacy
Medical Devices - the course is an elective obligatory course of the Master study program Pharmacy 2nd (Master)
V.2 - Overview of the responsibility for the delivery, development and quality assurance of the study programme or its part at the university in the current academic year
V.2.a - Name of the study programme V.2.b - Degree V.2.c - Field of study
Medical and Diagnostic Devices Bachelor (1st Degree) Healtcare Sciences
Pharmacy Master (2nd Degree) Pharmacy
V.3 - Overview of the responsibility for the development and quality of the field of habilitation procedure and inaugural procedure in the current academic year
V.3.a - Name of the field of habilitation procedure and inaugural procedure V.3.b - Study field to which it is assigned
NA NA
NA NA
NA
NA
V.4 - Overview of supervised final theses
V.4.1 - Number of currently supervised theses
V.4.a - Bachelor's (first degree)
0
V.4.b - Diploma (second degree)
0
V.4.c - Dissertation (third degree)
NA
V.4.2 - Number of defended theses
V.4.a - Bachelor's (first degree)
6
V.4.b - Diploma (second degree)
8
V.4.c - Dissertation (third degree)
NA
V.5 - Overview of other courses taught in the current academic year according to study programmes
V.5.a - Name of the course V.5.b - Study programme V.5.c - Degree V.5.d - Field of study
Good Manufacturing Practice in Pharmaceuticals Pharmacy (in the SK Course) Master Pharmacy
Good Manufacturing Practice in Pharmaceuticals Pharmacy (in English Program) Master Pharmacy
Medical Devices Medical and Diagnostic Devices Bachelor Health Sciences

VI. - Overview of the research/artistic/other outputs

VI.1 - Overview of the research/artistic/other outputs and the corresponding citations
VI.1.1 - Number of the research/artistic/other outputs
VI.1.a - Overall
20
VI.1.b - Over the last six years
15
VI.1.2 - Number of the research/artistic/other outputs registered in the Web of Science or Scopus databases
VI.1.a - Overall
3
VI.1.b - Over the last six years
3
VI.1.3 - Number of citations corresponding to the research/artistic/other outputs
VI.1.a - Overall
10
VI.1.b - Over the last six years
10
VI.1.4 - Number of citations registered in the Web of Science or Scopus databases
VI.1.a - Overall
10
VI.1.b - Over the last six years
10
VI.1.5 - Number of invited lectures at the international, national level
VI.1.a - Overall
1
VI.1.b - Over the last six years
1
VI.2 - The most significant research/artistic/other outputs
1

Factors Influencing Persistence of Diphtheria Immunity and Immune Response to a Booster Dose in Healthy Slovak Adults

Authors: Marek Petráš, Vladimír Oleár, Milica Molitorisová, et al.


Published in 2019, Vaccines [online], Vol. 7, no 4 (2019), p. 1-9, art. no.139


Key outcomes


Booster immunisation against diphtheria in adults carried out with bivalent tetanus-diphtheria vaccines produced a protective immune response dependent on persistent levels of diphtheria antibodies prior to the booster dose. The persistence of antibody levels is the key predictor of seroprotection achievement correlating with time since the last vaccination.

Therefore, two-dose vaccination should be considered, in an emergency, in recipients with the last dose received >34 years earlier. Based on our data, we can further anticipate a higher increase in diphtheria antibodies more often in non-smokers and in adults without statin treatment. If these factors have any clinical impact on protection against diphtheria is yet to be established.

2

Support of medication adherence by community pharmacists in Czech and Slovak Republics: a

questionnaire survey study

Authors: Milica Molitorisová , Iveta Waczulíková, Jana Kotlářová... [et al.]


Published in 2018, European Pharmaceutical Journal [online], Vol 65, No 1 (2018), p. 15-23; SCOPUS




Key outcomes



Intervention of pharmacists in medication adherence can meaningfully contribute to achieving therapeutic

outcomes. Exploring the real-life readiness and opportunities of pharmacists may result in the adoption of measures, which could be seen through improvement of patients ́ adherence to pharmacotherapy.

The pharmaceutical care is developing towards the improvement of medication adherence in both countries, the Czech Republic and Slovakia, assuming a medium degree of adherence support. Further progress may be observed in strengthening the pharmacists’ personnel capacities, and accelerated mainly using information technologies, i.e. through technical capacities.



3

Characterization of bioactive substances MHGF-68 on tumour cell lines with LiveFlow In Vitro Technology

Autori: Richard Hodoši, E., Nováková, K. Macková, Molitorisová M.,Supolikova,M.


Citations 2


Abstract:

As part of experimental research, growth factor-like substances associated with MHV-68, named MHGF-68, were discovered in our laboratory. MHGF-68 activity was manifested by the ability to alter cell morphology, that is, normal phenotype to transformed, resp. suppresses the transformed phenotype of tumour cells. The aim of the experiments was to monitor the effect of MHGF-68 on the change of the cell actin cytoskeleton in the tumour cell line Hepa1c1c7, as well as the normal cell line NIH3T3, and compare conventional stationary cultivation and dynamic cultivation conditions using a LiveFlow system (In Vitro Technologies). LiveFlow is an advanced system to test the impact of different compounds on the cell cultures, which allows simulation of in vivo conditions thanks to continuous flow of cultivation medium. MHGF-68 was prepared with the infection of BHK-21 cells with MHV-68 virus under non-permissive conditions (41°C). After dynamic cultivation with MHGF-68, we observed changes in morphology on Hepa1c1c7 cells. In cells cultured in a dynamic environment, we observed more pronounced changes in cell morphology in comparison with cells cultured statically. We observed no changes in the cytoskeletal structures in the NIH 3T3 cell line affected by MHGF-68 in both types of cultivation. The advantage of LiveFlow in comparison to in vivo testing is that the experiments performed in this system are less time and money consuming. Dynamic cultivation in the LiveFlow system is suitable for optimizing experiments before testing substances in vivo.

VI.3 - The most significant research/artistic/other outputs over the last six years
VI.4 - The most significant citations corresponding to the research/artistic/other outputs
1

Factors Influencing Persistence of Diphtheria Immunity and Immune Response to a Booster Dose in Healthy Slovak Adults

Authors: Marek Petráš, Vladimír Oleár, Milica Molitorisová, et al.


Published in 2019, Vaccines [elektronický dokument]. - Vol 7, no 4 (2019), s. 1-9, art. no.139 [online]


Key citations:


  • [n1] 2021 - Torres-Rives, B. - Martínez-Téllez, G. - Matarán-Valdés, M. - Osorio-Ilas, L. - Vilches-Lescaille, D. - Rodríguez-Pelier, C. - Zúniga-Rosales, Y. - Collazo-Mesa, T. - In: VacciMonitor, Vol. 30, no. 1, 2021; p. 10-17 ; SCOPUS
  • [n1] 2021 - Lesichkova, S. - Mihailova, S. - Mihaylova, A. - Gesheva, N. - Yankova, P. - Naumova, E. - In: Acta Medica Bulgarica, Vol. 48, no. 1, 2021 ; p. 46-52 ; SCOPUS
  • [n1] 2022 - Ferrara, P. - Gianfredi, V. - Tomaselli, V. - Polosa, R. - In: Vaccines, Vol. 10, no. 2, 2022 ; art. no. 303 ; SCI ; SCOPUS
2

Support of medication adherence by community pharmacists in Czech and Slovak Republics: a

questionnaire survey study

Authors: Milica Molitorisová , Iveta Waczulíková, Jana Kotlářová... [et al.]


Published in 2018, European Pharmaceutical Journal [online]. - Vol. 65, no. 1 (2018), p. 15-23; SCOPUS


Key citations


2020 - Parente, M. - Pignata, I. - Gnavi, R. - Spadea, T. - Di Martino, M. - Baratta, F. - Brusa, P. : Assessment of non-adherence to oral metformin and atorvastatin therapies: A cross-sectional survey in piedmont (Italy). - In: Patient Preference and Adherence, Vol. 14, 2020 ; pp. 261-266 ; SCOPUS Signature MF18-0151

VI.5 - Participation in conducting (leading) the most important research projects or art projects over the last six years

VII. - Overview of organizational experience related to higher education and research/artistic/other activities

VII.a - Activity, position VII.b - Name of the institution, board VII.c - Duration
Organization of the 38th Days of Technology Days, scientific conference, Head of the Department Comenius University Bratislava, Faculty of Pharmacy 2 days
70th Anniversary of the Faculty of Pharmacy Comenius University Bratislava, Faculty of Pharmacy 6 months
Head of the Faculty´s Council of the quality implementation in higher education Comenius University Bratislava, Faculty of Pharmacy since 2021 - current

VIII. - Overview of international mobilities and visits oriented on education and research/artistic/other activities in the given field of study

IX. - Other relevant facts

Date of last update
2024-04-29